Medical Patent Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Macular Degeneration
Studies from Emory University have provided new information about macular degeneration
January 25th, 2008
In this recent report, researchers in the United States conducted a study "To report the histopathological findings after photodynamic therapy (PDT) in eyes obtained postmortem with choroidal neovascularisation (CNV) secondary to age-related macular degeneration (AMD). Two eyes were obtained postmortem from two patients with CNV secondary to AMD." "Both of the patients had been treated with PDT. Serial sections through the posterior poles were obtained and stained with haematoxylin-eosin, periodic acid-Schiff, Masson trichrome or phosphotungstic acid haematoxylin (PTAH). Two-dimensional reconstructions were prepared and compared with fluorescein angiograms. The interval...
Source: Medical Patent Business Week (2008-01-25)
|
